Recent Articles By The Author
It seemed just a matter of time before M&A returned to the biotech industry with a vengeance.
These rules can help investors who are digging through the rubble that 2018 left behind in the biotech sector.
And how to position your portfolio to minimize the impact.
Chatham Lodging Trust and HanesBrands offer nice payouts while waiting out the current market storm.
The Federal Reserve definitely is more confident in its forecasts than it should be based on its track record over the last decade.
Entercom Communications, W.R. Grace, Newmark Group and a few airlines are seeing insider purchases.
Bad news appears fully priced into these equities.
Quotient Limited, Iovance Biotherapeutics and AVEO Pharmaceuticals are among the names seeing insider purchases.